Dr Reddy’s Lab launches generic version of Amoxil tablets

20 Sep 2012 Evaluate

Dr Reddy’s Laboratories, has launched Amoxicillin tablets Capsules and Oral Suspension, a bioequivalent generic version of Amoxil tablets, capsules and Oral Suspension in the US markets on September 17, 2012. Amoxicillin tablets (500 mg and 875 mg), capsules (250 mg and 500 mg) and Oral Suspension (125 mg/5ml, 200mg/5 ml and 400 mg/5ml) are approved by United States Food and Drug Administration (USFDA).

Dr Reddy’s Amoxicillin tablets in 500 mg and 875 mg are available in bottle counts of 20 and 100. Amoxicillin capsules in 250 mg and 500 mg are available in bottle counts of 100 and 500, while Amoxicillin oral suspension in 200 mg mg/5ml and 400 mg/5ml are available in bottle sizes of 50 ml, 75 ml and 100 ml.

The Amoxil brand and generic tablets (875 mg) has US sales of approximately $22.2 million. Out of which capsules have sales of approximately $67.2 million and oral suspension has US sales of approximately $89.5 million, all for the most twelve months ending June 2012, according to IMS Health.

Dr. Reddys Lab Share Price

1259.20 -7.95 (-0.63%)
09-Dec-2025 12:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1259.20
Cipla 1499.40
Zydus Lifesciences 920.40
Lupin 2060.40
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×